# Sources — Booker T. Washington

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 2, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. U.S. National Park Service, Tuskegee Institute National Historic Site. “Booker T. Washington.” Supports his birth into slavery on the James Burroughs plantation in Franklin County, Virginia, in 1856, his arrival at Tuskegee in 1881, and his death on November 14, 1915, at 59, “due to conditions related to high blood pressure.” https://home.nps.gov/tuin/learn/historyculture/booker-t-washington.htm
2. U.S. National Park Service, Booker T. Washington National Monument. “Washington Timeline.” Supports the birth date of April 5, 1856, the 1865 move to Malden, West Virginia, work in the salt and coal mines, the opening of Tuskegee Institute on July 4, 1881, National Negro Health Week in March 1915, and his death at Tuskegee on November 14, 1915. https://www.nps.gov/bowa/learn/historyculture/washington-timeline.htm
3. U.S. National Park Service, Booker T. Washington National Monument. “The Death of Booker T. Washington” (site bulletin). Reprints the New York Times obituary of November 15, 1915, and an annotated version of the Rockefeller Hospital record presented at the 2006 Historical Clinicopathological Conference of the University of Maryland School of Medicine and the VA Maryland Health Care System. Supports the Bright's disease diagnosis by Drs. Bastedo and Cole, the November 2, 1915 record (blood pressure 220/150, palpitations, fatigue, frontal headaches, slowed thinking, weight loss, failing vision, frequent urination, thirst, negative Wassermann), the 1911 assault and chronic indigestion, the “racial characteristics” remark and Dr. George C. Hall's reading of it, and Dr. Jackson T. Wright Jr.'s conclusion of malignant hypertension with kidney failure. https://www.nps.gov/bowa/learn/historyculture/upload/the-final-btwdeath-site-bulletin.pdf
4. Black B. “The Strange Case of Booker T. Washington's Birthday.” *Contingent Magazine*, April 5, 2021. Supports Washington's own uncertainty about his birth date (he estimated 1858 or 1859 in *Up from Slavery*) and the origin of the April 5, 1856 date in his brother John's report after his death. https://contingentmagazine.org/2021/04/05/the-strange-case-of-booker-t-washingtons-birthday/
5. U.S. National Park Service, Booker T. Washington National Monument. “Footprints: Women Who Influenced Booker T. Washington” (news release). Gives his mother Jane's dates as “?–1876” and her life in Malden after emancipation. https://home.nps.gov/bowa/learn/news/footprints-women-who-influenced-booker-t-washington.htm
6. HISTMED Master Roster v3. Internal project source. Its clinical claims were provisional and were not treated as independent corroboration.

## Clinical guidance

1. 2025 AHA/ACC multisociety Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Blood pressure target below 130/80; outpatient management of severe hypertension without acute target-organ damage. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001356
2. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. *Kidney Int* 2024;105(4S):S117–S314. Risk staging by eGFR and albuminuria, maximum-dose renin-angiotensin blockade, SGLT2 inhibitors, statins, referral criteria, and the kidney failure risk equation. https://doi.org/10.1016/j.kint.2023.10.018
3. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. *Kidney Int* 2021;99(3S):S1–S87. Standardized office systolic target below 120 when tolerated. https://doi.org/10.1016/j.kint.2020.11.003
4. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), hypertension and chronic kidney disease monographs. Potassium and creatinine two to four weeks after starting or titrating renin-angiotensin, SGLT2 inhibitor, or diuretic therapy; eGFR and UACR about three times a year for G3b A3; hemoglobin at least yearly in G3; calcium, phosphate, and PTH every six to twelve months in G3; annual kidney failure risk; annual funduscopic examination and PHQ-9 in hypertension; ECG at diagnosis and echocardiogram for stage 2 hypertension. https://patrickrutledge.github.io/topthirty/
5. Qaseem A, Wilt TJ, McLean RM, Forciea MA; Clinical Guidelines Committee of the American College of Physicians. “Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians.” *Ann Intern Med* 2017;166(7):514–530. Superficial heat and staying active first for acute low back pain, with NSAIDs or skeletal muscle relaxants as options; no imaging without red flags. NSAIDs are not used here because of his kidney disease (KDIGO 2024). Used for the sick visit. https://pubmed.ncbi.nlm.nih.gov/28192789/
6. U.S. Preventive Services Task Force. A and B Recommendations. The adult preventive services offered at the preventive visit, including one-time hepatitis C and HIV screening, blood pressure, statin, diabetes, depression, and unhealthy alcohol use screening, and healthy diet and activity counseling. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations
7. U.S. Preventive Services Task Force. Colorectal Cancer: Screening (2021), and Prostate Cancer: Screening (2018). Colorectal screening from 45 to 75; individual decision-making about PSA testing from 55 to 69, with the statement's note on higher risk in Black men. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening and https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening

## Editorial resolutions

- **Birth date.** Washington did not know his birth date. The National Park Service timeline gives April 5, 1856, which traces to his brother's report after his death; Washington himself estimated 1858 or 1859. The case uses April 5, 1856 as preferred, records 1858 or 1859 as a conflicting alternative, and keeps April 5 in the synthetic date of birth (1967-04-05).
- **Index age and date.** The modern episode presents Washington at 59, his age at the documented November 2, 1915 admission. That date cannot be used in the modern frame because the publication cutoff is November 1, 2026, and visits must also fall before his death on November 14 when shifted back by 111 years. The index visit is May 4, 2026 (true frame May 4, 1915), in the months of failing health the obituary describes, and the last visit is October 26, 2026 (true frame October 26, 1915). The 1915 admission and his death therefore fall after the index date and are left out of the past medical history; they remain in the historical timeline.
- **Modern diagnosis.** Bright's disease (1915) and malignant hypertension with kidney failure (2006 review, graded **R**) are linked to, but not equated with, the synthetic diagnosis of hypertensive chronic kidney disease stage G3b A3. The synthetic episode deliberately presents him earlier and without a hypertensive emergency, so outpatient treatment is appropriate; the intake blood pressure of 212/128 echoes, but is not, the documented 220/150.
- **Biased attribution.** Dr. Bastedo's 1915 “racial characteristics” remark and the syphilis rumor it fed are recorded as a sensitive claim (**D**) only with the negative Wassermann result and the 2006 review alongside them. The synthetic workup does not repeat syphilis testing.
- **Sick and preventive visits.** Two visits were added between the four-week and six-month reviews: an unscheduled sick visit on August 10, 2026 (true frame August 10, 1915) for an acute lumbar strain, and a periodic adult preventive visit on September 21, 2026 (true frame September 21, 1915). Both fall well before the November 1915 admission and are synthetic. He is 59, so the visit follows USPSTF adult preventive services rather than a Medicare wellness visit. The back strain does not echo a documented illness. It was chosen because self-treatment with an over-the-counter NSAID is a common and teachable hazard with losartan, a thiazide-like diuretic, and an SGLT2 inhibitor in stage G3b kidney disease; the same-day creatinine is kept unchanged from June so that the lesson is prevention rather than injury. The preventive visit keeps the care plan's decision not to repeat LDL, adapts the colonoscopy preparation to his kidney disease, and offers hepatitis C and HIV screening explicitly as universal one-time screens, not as risk-based tests; no syphilis testing is added, consistent with the decision above. The PSA discussion cites the USPSTF note on higher prostate cancer risk in Black men as a population statistic, not as an attribution about him. The PSA and the hepatitis C and HIV screens are ordered for the October draw and their results are not recorded. Its advance care planning names no real person as his health care agent.
- **Focused visits.** The four chronic-care follow-ups (one week, three weeks, four weeks, and six months) are documented as focused visits on the CMID hypertension and chronic kidney disease monographs, with the anemia-of-CKD items and the hyperlipidemia monograph where they apply. Each visit lists every item the protocols call for at that point, with its interval and status. The potassium and creatinine checks after each change fall in or before the window: one week after starting losartan (earlier than the CMID two to four weeks because of severe hypertension, within the care plan's one to four weeks), three weeks after the losartan increase and dapagliflozin start, and four weeks after chlorthalidone. Synthetic findings introduced: standardized office readings described as two-reading averages, an S4 on examination, undilated funduscopy at the one-week visit, interval home readings, symptoms, and travel details consistent with the existing record. Protocol deviations recorded instead of invented results: no urinalysis with microscopy from the diagnostic workup (not repeated later because his status did not change); no kidney failure risk calculation before the nephrology referral (first calculated at six months); and no baseline 25-hydroxyvitamin D, planned for the six-month draw and still not drawn then. No harm is evident from any of them. The lipid monograph's 4 to 12 week and yearly lipid panels are recorded as not indicated, a deliberate departure that follows the CKD monograph and KDIGO and the care plan's existing decision not to repeat LDL. The six-month note says that the PSA and hepatitis C and HIV screens ordered at the preventive visit were added to that draw; their results are not recorded.
- **Consultation.** The nephrology referral and Dr. Oyelaran's consultation on the day of the one-week visit are synthetic and are written to agree with the record: the losartan increase, dapagliflozin start, vaccinations, the later chlorthalidone step, and the six-month results sent back to nephrology. Synthetic details introduced: no abdominal bruit on examination and a symmetric description of the recorded ultrasound. Judgment calls: (1) urinalysis with microscopy and any further workup for other kidney diseases are made conditional on albuminuria not falling, matching the deviation and corrective action recorded at the visit; albuminuria later fell by 71 percent; (2) secondary-hypertension testing is reserved for blood pressure above target on three agents, which did not occur; (3) the kidney failure risk is deferred until eGFR settles, matching its first calculation at six months; (4) consistent with the decisions above, the consultation adds no syphilis testing and no race-based testing or attribution, and the hepatitis C and HIV screens stay with the preventive visit.
- **Mother's death.** The NPS release gives 1876; other accounts give 1874. The case uses 1876 with that caveat and records no cause.
- **Not used.** His father was an unidentified white man, so no paternal history is recorded. His wives' deaths are not family medical history. His children's later illnesses happened after the index date and are not recorded. A 2006 statement that he died of hypertensive cardiomyopathy and nephrosclerosis appeared in search summaries but was not confirmed in a fetched source and is not used.
- Washington died in 1915, so the recent-death review rule does not apply. Ordinary clinical, provenance, and safe-messaging reviews remain required.
